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Pannexin1 is ubiquitously expressed in vertebrate tissues, but the role it plays in vascular tone regulation remains
unclear. We found that Pannexin1 expression level is much higher in the endothelium relative to smooth muscle
of saphenous artery. The ability of endothelium-intact arteries for dilation was significantly impaired whereas
contractile responses were considerably increased in mice with genetic ablation of Pannexin1. No such increased
contractile responses were detected in the endothelium-denuded arteries. Combined, our findings suggest a new
function of Pannexin1 as an important player in normal endothelium-dependent regulation of arterial tone, where
it facilitates vessel dilation and attenuates constriction.
Reviewed by Dr. Armen Mulkidjanian and Dr. Alexander Lobkovsky.
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Introduction
Cell-to-cell communication provides coordination of cel-
lular processes in multicellular organisms. In the vascular
system, multilayer communication takes place between
cells of different types [1]. Known mechanisms underlying
this essential communication include gap junctions (GJ)
[1,2] and paracrine action of signaling molecules, such as
ATP [3]. GJ are composed of the connexin family of
proteins that connect the cytoplasm of adjacent cells by
forming a transmembrane channel permeable to ions and
small molecules. Connexins, identified as the molecular
components of GJ almost 30 years ago [2], were only
found in chordates [4,5]. Different family of functionally
similar but structurally unrelated GJ proteins was found
in invertebrates. This family of specific invertebrate GJ
proteins was originally designated OPUS [6] and, later
renamed into innexins [7]. After innexin homologs were
discovered in Humans and other vertebrates, it was
proposed to reclassify them along with their vertebrate
homologs into a bigger family, named pannexins [8,9].* Correspondence: Dina.Gaynullina@gmail.com
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article, unless otherwise stated.Mammalian pannexins has three family members (Panx1,
2 and 3) that are involved in GJ formation [10,12] and/or
form hemichannels implicated in the release of ATP and
other small molecules from the cytoplasm into extracel-
lular milieu. Some investigators claim that vertebrate
pannexins form only hemichannels in vivo [13,14]. Since
pannexins are involved in intercellular communication
that is essential for the functioning of the vascular system
[1], the presence (or absence) of pannexins will affect
blood flow regulation.
Two major functional components of vascular wall are
smooth muscle and endothelium. The endothelium me-
diates vasodilator effects of many blood-circulating hor-
mones and locally acting autacoids [15]. In addition, the
endothelium may tonically suppress vessel constriction
even without direct activation; the phenomenon assigned
as an anticontractile effect of the endothelium [16,17].
Noteworthy, the impaired endothelial function in both
resistance-size and larger conduit arteries is considered a
major cause of many cardiovascular disorders [18].
In murine systemic arterial network Panx1 is the
primary expressed isoform [19]. Panx1 is abundant in
endothelium of all arteries [19] and capillaries [5], but
the pattern of Panx1 expression depends on the vessel
size. In contrast to larger conduit arteries where Panx1
is expressed primarily in the endothelium, in smaller re-
sistance arteries it is also expressed in smooth muscletral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
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essential pathway for ATP release that potentiates skel-
etal muscle contraction [20]. By similarity, in the smooth
muscle of small arteries, Panx1-mediated ATP release
was shown to participate in vascular tone regulation by
potentiating arterial contractile response to α1-adreno-
ceptor activation [21]. However, functional role of Panx1
in facilitating vasodilator and anticontractile effects of
the endothelium has never been studied before.
This study, for the first time, presents evidences sup-
porting a critical role of Panx1 in endothelium-dependent
component of vessel dilation mechanism. Since truly
selective pharmacological blockers of the Panx1 channel
currently are not available, we utilized Panx1−/− mice as
the ultimate test model for investigating functional signifi-
cance of Panx1 activity in vascular system regulation.
Results and discussion
Lohman et al. [19] used immunohistochemistry to reveal
primarily endothelial localization of Panx1 in murine
systemic conduit arteries. However, due to poor specifi-
city of most available antibodies against this proteinFigure 1 Endothelial function is impaired in saphenous arteries of Pa
expression levels in endothelium-intact (+Endo) and endothelium-denuded
*p < 0.05,). Data were normalized to the amount of smooth muscle cells m
corresponding endothelium-intact (+Endo) group. (B) Concentration-respon
phenylephrine of endothelium-denuded (thin curves; n = 11, 10, p = 0.14) or
arteries from WT and Panx1−/− mice. (C) Concentration-response relationsh
Panx1−/−mice to KCl (n = 6; 9, *p < 0.05; the effect of noradrenaline released
(D) Concentration-response relationships to acetylcholine after phenylephr
from WT and Panx1−/−mice (n = 6, 6, *p < 0.05).[22], quantitative immunohistochemistry data for Panx1
remains rather unreliable. Here, we addressed this con-
cern by alternative, more quantitative approach, i.e. by
comparing Panx1 gene expression levels in endothelium-
intact and endothelium-denuded arterial preparations
(Figure 1A; Additional file 1: Figure S1). As expected, the
disruption of the endothelium caused significant reduction
of the transcript for endothelial marker CD31. Accord-
ingly, the endothelium removal resulted in a considerable
drop in the Panx1 transcript, thus indicating that Panx1 is
expressed predominantly in endothelial cells of murine sa-
phenous artery. In the saphenous arteries from Panx1−/−
mice, no Panx1 transcript has been detected by PCR amp-
lification with the same primers.
Vascular tone in rodent saphenous artery is regulated
mainly by sympathetic nerves that release noradrenaline,
which causes vasoconstriction predominantly through
α1-adrenoceptors. To mimic the constrictor effects of
noradrenaline, we examined contractile responses to α1-
adrenergic agonist phenylephrine and the regulatory role
of endothelium in these contractions in WT and Panx1−/−
mice. The α1-adrenoceptors are located only on smoothnx1−/−mice. (A) Relative CD31/SM22 and Panx1/SM22 mRNA
(−Endo) arteries of WT mice (n = 4; 4 for CD31 and n = 3; 4 for Panx1;
arker SM22 mRNA and expressed as % of the average level in
se relationships to cumulative addition of α1-adrenoceptor agonist
endothelium-intact (thick curves; n = 22, 24, *p < 0.05) saphenous
ips of endothelium-intact saphenous arteries from WT and
from sympathetic nerves was blocked by 1 μmol/L phentolamine).
ine-induced preconstruction of endothelium-intact saphenous arteries
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rine stimulates primarily smooth muscle. Phenylephrine-
induced contractile responses of endothelium-denuded
arteries did not differ in WTand Panx1−/− mice (Figure 1B),
which is in good agreement with predominantly endo-
thelial localization of Panx1 in murine saphenous arteries
(Figure 1A).
In WT mice, the endothelium-intact arteries were less
sensitive to phenylephrine compared to endothelium-
denuded arteries (Figure 1B) due to the anticontractile
action of the endothelium [16,17]. Importantly, such in-
fluence of the endothelium in the arteries from Panx1−/−
was prominently weaker than that in WT mice. This is
consistent with a model where Panx1 mediates and the
ablation of Panx1 attenuates the anticontractile action of
the endothelium. As Figure 1B shows, when phenyleph-
rine was applied in concentration of 2*10−7 M (point −6.7)
the responses in KO mice were more than two-fold stron-
ger than in WT mice. Quantitatively, Panx1 activity can
be accounted for approximately half of the anticontractile
action of the endothelium.
Noteworthy, phenylephrine can be taken up by periar-
terial sympathetic nerves similar to a natural transmitter,
noradrenaline. Therefore, the observed differences be-
tween WT and Panx1−/−mice (Figure 1B) might be ex-
plained by altered neuronal uptake, as was demonstrated
in vessel denervation model [23]. However, the enhance-
ment of contractile responses in endothelium-intact
arteries in Panx1−/− vs. WT mice was also observed dur-
ing application of methoxamine (Additional file 2: Figure
S2), which activates α1-adrenoceptors but is not taken up by
sympathetic nerves [24]. Similar enhancement was observed
when the contractile response was induced by non-receptor
activation by high-K+ depolarization (Figure 1C). This
demonstrates that anticontractile effect of Panx1 is not
restricted to α1-adrenergic agonists and may appear in
response to a variety of stimuli.
Another strong evidence for functional role of Panx1
in the endothelium was obtained by comparing the
acetylcholine-induced relaxations of endothelium-intact
arteries in WT and Panx1−/− mice. Acetylcholine affects
arterial tone exclusively though receptors on endothelial
cells, therefore the endothelium-denuded arteries do not
dilate to acetylcholine (data not shown). We found that
the response to acetylcholine was significantly weaker in
Panx1−/− vs. WT saphenous arteries (Figure 1D), indicat-
ing that Panx1 participates in the regulation of the
endothelium-dependent dilatory mechanisms.
Three putative Panx1-mediated pathways in the vas-
cular endothelium are worth further exploration: either
Panx1-formed gap junction channels interconnecting
endothelial cells, as suggested previously [5] or via
Panx1 hemichannel-mediated Ca2+-influx, and/or ATP
release [25,26]. Extracellular ATP may induce relaxationeither itself, via endothelial P2 receptors [3], or after
degradation by ectonucleotidases to adenosine, a potent
vascular dilator [3,27]. Our findings of the decreased
endothelium-dependent relaxation and the anticontrac-
tile action of the endothelium in Panx1−/− mice suggest
the participation of Panx1 in these mechanisms.
In conclusion, our data demonstrate for the first time
that Panx1 is involved in the regulation of endothelium-
dependent relaxation of conduit arteries. We show that
Panx1 mediates endothelial contribution to the adrenergic-
induced contractions, thereby modulating vascular tone.
The results of this study suggest that activity of Panx1 in
the endothelium of conduit arteries is important for con-
trol of blood supply to different organs. Activation of the
endothelium in conduit arteries during episodes of mech-
anical stimulation (shear stress) by increased blood flow
ensures their dilation and thereby stabilizes pressure drop
along the proximal site of vascular bed [28]. Therefore, the
blockade or ablation of Panx1 in the endothelium may
disturb a proper adjustment of proximal and distal vascular
resistances, a necessary condition for adequate control of




Panx1−/− mouse strain was described previously [29]. All ex-
periments in this study were performed in full compliance
with the NIH Guide for the Care and Use of Laboratory An-
imals and Russian national guidelines for animal research.
The protocols were approved by University of Miami
IACUC (protocol #12-051) and Institute for Information
Transmission Problems, Russian Academy of Sciences
IACUC (protocol #02-2013). Wild type (WT) animals were
age-matched (2–3 months old) male mice of the C57BL/6
background. Mice were housed under standard conditions
of temperature and humidity, with a 12-hour light/dark
cycle and free access to food and water. Mean body weights:
WT – 28.9 ± 0.6 g, Panx1−/− - 26.2 ± 0.4 g (p < 0.05).
The experiments were performed using the prepara-
tions of the saphenous artery, which branches off from
the femoral artery at the level of the knee and supplies
blood to the foot [30]. The inner diameters of saphenous
arteries in WT and Panx1−/−mice were 272.4 ± 5.5 micron
and 304.9 ± 5.8 micron respectively. For force recording,
2-mm ring preparations were mounted in isometric myo-
graph [31] (for details see Additional file 3). Standard
methods were used for gene expression and statistical ana-
lysis (see Additional file 3).
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quences of Panx1 deficiency.
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The article presents measurements of contractile response
of mammalian (mouse) arteries to several stimuli in mice
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vessel. The conclusion namely that Panx1 is involved
regulation of endothelium dependent relaxation of blood
vessels is well supported and clearly argued. Methods
(both in the lab and data analysis) are clearly stated and
whenever statistical significance is claimed, appropriate
p-values are computed.
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